CompaniesByCap
CLDX
Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare

Celldex Therapeutics Inc. Cash Flow 2009–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-210.9M-157.8M-107.3M-103.7M-60.9M-40.4M-46.4M-75.2M-99.9M-113.0M-98.9M
Depreciation & Amort.3.4M3.2M3.0M2.9M3.1M3.9M4.9M3.6M4.4M3.1M3.0M
Investing Activities
Capital Expenditure2.7M1.9M1.8M1.8M1.2M1.6M731,000813,0001.8M2.8M4.9M
Free Cash Flow-213.7M-159.7M-109.1M-105.6M-62.2M-42.0M-47.1M-76.0M-101.7M-115.8M-103.8M
Financing Activities
Dividends Paid
Stock Buybacks

Celldex Therapeutics Inc. Cash Flow — FAQ

Celldex Therapeutics Inc. (CLDX) cash flow over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CLDX's cash flow history?

The chart and table above show Celldex Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.